Patient-Derived Orthotopic Xenograft models in gastric cancer: a systematic review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
http://link.springer.com/content/pdf/10.1007/s13304-020-00751-4.pdf
Reference36 articles.
1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
2. Bang Y-J, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697. https://doi.org/10.1016/S0140-6736(10)61121-X
3. Fuchs CS, Tomasek J, Yong CJ et al (2014) Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet (London, England) 383:31–39. https://doi.org/10.1016/S0140-6736(13)61719-5
4. Kamath SD, Kalyan A, Benson AB (2018) Pembrolizumab for the treatment of gastric cancer. Expert Rev Anticancer Ther 18:1177–1187. https://doi.org/10.1080/14737140.2018.1526084
5. Bertotti A, Bracco C, Girolami F et al (2010) Inhibition of Src impairs the growth of met-addicted gastric tumors. Clin Cancer Res 16:3933–3943. https://doi.org/10.1158/1078-0432.CCR-10-0106
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft Models;International Journal of Molecular Sciences;2024-01-25
2. Gastric cancer modeling in immunodeficient mice with orthotopic xenotransplantation;South Russian Journal of Cancer;2023-08-07
3. Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions;eBioMedicine;2023-06
4. OncoVee™-MiniPDX-guided anticancer treatment for HER2-negative intermediate-advanced gastric cancer patients: a single-arm, open-label phase I clinical study;Discover Oncology;2023-04-24
5. OncoVee TM -MiniPDX-guided anticancer treatment for HER2-negative intermediate-advanced gastric cancer patients: A single-arm, open-label phase I clinical study;2023-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3